We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West Ventures aims to foster innovative technologies that improve patient health and enhance drug delivery. By combining early-stage funding with West’s 100 years of expertise in integrated containment and delivery solutions, wearable devices, and digital technology, we can help turn today’s ideas into the products of tomorrow.
Our approach/intent is to create mutually beneficial partnerships where West’s expertise can provide added value and accelerate the development and delivery of our partners’ products to the market. We achieve this through strategic investments and providing our partners access to West’s extensive scientific, global manufacturing, and commercial capabilities.
Next-generation materials and surface treatments for primary drug containers and delivery components that improve stability, safety, and performance of sensitive small molecules, biologics, and cell/gene therapies.
Technologies that enable subcutaneous or other patient‑friendly delivery of biologics formulated at high concentrations and/or large volumes, which typically exhibit high viscosity and pose injection‑force, stability, and tolerability challenges.
Specialized aseptic manufacturing technologies and services that CDMOs use to perform sterile fill‑finish, with emphasis on modern, Annex 1‑aligned capabilities, high‑precision filling, low‑volume and cryo‑handling for biologics/CGTs, automated visual inspection, and end‑to‑end tech transfer and validation.
Technologies that administer drugs without hypodermic needles, such as jet injectors, microneedle patches, intradermal microneedle devices, and transdermal/physical enhancement methods—while prioritizing patient experience, safety, and usability.
Software and hardware tools, such as AI-driven analytics, digital-twin/simulation platforms, and advanced robotic/automation systems that accelerate and de-risk R&D and pilot-scale manufacturing.
Specialized technologies, manufacturing processes, and containment systems required to develop, produce, and deliver cell and gene therapies (CGTs) safely and at scale.
Combining advanced delivery and administration components/devices (e.g., self‑injection systems, administration sets, and related high‑precision plastic components) with sensors, connectivity, and software for at‑home data capture and clinical decision support.
MEDX Xelerator is an Israel-based, medical-device-focused incubator and investor operating under the Israel Innovation Authority that identifies and nurtures early-stage startups addressing major unmet clinical needs in areas like vascular, interventional cardiology, urology, oncology, robotics, and remote therapy.
The European Institute of Innovation and Technology (EIT) is an independent EU body established in 2008 that strengthens Europe’s innovation capacity by integrating business, research, and education through pan‑European Knowledge and Innovation Communities (KICs) focused on major societal challenges (e.g., health, climate, energy, digital, raw materials).
VIC Ventures (often referenced alongside VIC Tech) is a U.S.-based life science venture studio that creates and scales early-stage companies by exclusively licensing high-impact technologies from top research institutions and then building dedicated startups around them with capital, leadership, and operational support.
English
Chinese
